These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20422876)

  • 1. Effect of hepatocyte growth factor on progression of liver metastasis in colorectal cancer.
    Osada S; Matsui S; Komori S; Yamada J; Sanada Y; Ihawa A; Tanaka Y; Tokuyama Y; Okumura N; Nonaka K; Hosono Y; Takahashi T; Yamaguchi K; Yoshida K
    Hepatogastroenterology; 2010; 57(97):76-80. PubMed ID: 20422876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
    Wu F; Wu L; Zheng S; Ding W; Teng L; Wang Z; Ma Z; Zhao W
    Dig Liver Dis; 2006 Jul; 38(7):490-7. PubMed ID: 16627020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte growth factor levels in liver and blood, and post-operative liver cell proliferation in patients with benign and malignant liver tumors after partial hepatectomy.
    Dłuzniewska J; Zolich D; Polański J; Zajac L; Sitkiewicz D; Łukomska B
    Med Sci Monit; 2002 Oct; 8(10):CR690-6. PubMed ID: 12388921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum hepatocyte growth factor before and after resection for hepatocellular carcinoma.
    Hu RH; Lee PH; Yu SC; Sheu JC; Lai MY
    Hepatogastroenterology; 1999; 46(27):1842-7. PubMed ID: 10430357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of serum HGF and c-Met expression in tumor tissue for evaluation of properties and treatment of hepatocellular carcinoma.
    Osada S; Kanematsu M; Imai H; Goshima S
    Hepatogastroenterology; 2008; 55(82-83):544-9. PubMed ID: 18613405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases.
    Yoon SS; Kim SH; Gonen M; Heffernan NM; Detwiller KY; Jarnagin WR; D'Angelica M; Blumgart LH; Tanabe KK; Dematteo RP
    Ann Surg Oncol; 2006 Mar; 13(3):353-62. PubMed ID: 16474912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection.
    Chau GY; Lui WY; Chi CW; Chau YP; Li AF; Kao HL; Wu CW
    Eur J Surg Oncol; 2008 Mar; 34(3):333-8. PubMed ID: 17218078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases.
    Maithel SK; Gönen M; Ito H; Dematteo RP; Allen PJ; Fong Y; Blumgart LH; Jarnagin WR; D'Angelica MI
    Surgery; 2012 Feb; 151(2):162-70. PubMed ID: 21982065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma.
    Ueki T; Fujimoto J; Suzuki T; Yamamoto H; Okamoto E
    Hepatology; 1997 Mar; 25(3):619-23. PubMed ID: 9049208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma.
    Ueki T; Fujimoto J; Suzuki T; Yamamoto H; Okamoto E
    Hepatology; 1997 Apr; 25(4):862-6. PubMed ID: 9096589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of aggressive hepatectomy for colorectal liver metastasis, evaluated from the HGF/c-Met pathway.
    Matsui S; Osada S; Tomita H; Komori S; Mori R; Sanada Y; Takahashi T; Yamaguchi K; Yoshida K
    Int J Oncol; 2010 Aug; 37(2):289-97. PubMed ID: 20596656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
    Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portal and systemic serum growth factor and acute-phase response after laparotomy or partial hepatectomy in patients with colorectal liver metastases: a prognostic role for C-reactive protein and hepatocyte growth factor.
    de Jong KP; Hoedemakers RM; Fidler V; Bijzet J; Limburg PC; Peeters PM; de Vries EG; Slooff MJ
    Scand J Gastroenterol; 2004 Nov; 39(11):1141-8. PubMed ID: 15545174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of extracellular signal regulated kinase expression and its relation to treatment of hepatocellular carcinoma.
    Osada S; Kanematsu M; Imai H; Goshima S; Sugiyama Y
    J Am Coll Surg; 2005 Sep; 201(3):405-11. PubMed ID: 16125074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53 overexpression in colorectal metastases confined to the liver and outcome of liver resection.
    Heisterkamp J; van Bommel J; Hop WC; Tilanus HW; Zondervan PE; IJzermans JN
    Hepatogastroenterology; 1999; 46(30):3109-14. PubMed ID: 10626170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma.
    Topcu-Yilmaz P; Kiratli H; Saglam A; Söylemezoglu F; Hascelik G
    Melanoma Res; 2010 Apr; 20(2):126-32. PubMed ID: 20061986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solitary colorectal liver metastasis: resection determines outcome.
    Aloia TA; Vauthey JN; Loyer EM; Ribero D; Pawlik TM; Wei SH; Curley SA; Zorzi D; Abdalla EK
    Arch Surg; 2006 May; 141(5):460-6; discussion 466-7. PubMed ID: 16702517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory response to growth factors impairs liver regeneration after hepatectomy in patients with viral hepatitis.
    Umeda Y; Iwagaki H; Ozaki M; Ogino T; Iwamoto T; Yoshida R; Shinoura S; Matsuda H; Sadamori H; Tanaka N; Yagi T
    Hepatogastroenterology; 2009; 56(93):971-7. PubMed ID: 19760923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of postoperative transarterial infusion chemotherapy for liver metastasis of colorectal carcinoma after hepatectomy.
    Asahara T; Kikkawa M; Okajima M; Ojima Y; Toyota K; Nakahara H; Katayama K; Itamoto T; Marubayashi S; One E; Yahata H; Dohi K; Azuma K; Ito K
    Hepatogastroenterology; 1998; 45(21):805-11. PubMed ID: 9684138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.